These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1775435)

  • 1. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on the D2 dopaminergic receptor turnover in the rat brain.
    Nowak G; Zak J
    Pharmacol Toxicol; 1991 Aug; 69(2):87-9. PubMed ID: 1775435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain.
    Dziedzicka-Wasylewska M; Rogoz R; Klimek V; Maj J
    J Neural Transm (Vienna); 1997; 104(4-5):515-24. PubMed ID: 9295182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats.
    Nowak G; Zak J
    Eur J Pharmacol; 1989 Aug; 167(2):307-8. PubMed ID: 2687010
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
    Ekman A; Eriksson E
    Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of antidepressant drugs and electroconvulsive shock (ECS) on cortical alpha 1-adrenoceptors following destruction of dopaminergic nerve terminals.
    Nowak G
    Pharmacol Toxicol; 1989 May; 64(5):469-70. PubMed ID: 2549530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
    Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of antidepressant drugs and electroconvulsive shock on brain alpha 1-adrenoceptors following destruction of noradrenergic or serotonergic nerve terminals.
    Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1988; 40(4):393-400. PubMed ID: 2851781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study.
    Barkai AI; Durkin M; Nelson HD
    Brain Res; 1990 Oct; 529(1-2):208-13. PubMed ID: 2149297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS; George T; Baldessarini RJ
    Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on [3H] prazosin binding to different rat brain structures.
    Nowak G; Przegaliński E
    J Neural Transm; 1988; 71(1):57-64. PubMed ID: 2830364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The turnover of rat cortical alpha 1-adrenoceptors is not modified by repeated electroconvulsive treatment.
    Nowak G; Zak J
    J Neurochem; 1991 Jun; 56(6):2004-6. PubMed ID: 1673997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R; Dziedzicka-Wasylewska M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.
    Maj J; Klimek V; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1991; 86(1):11-23. PubMed ID: 1751026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
    Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
    Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(3):317-23. PubMed ID: 4070080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM; Joseph JA; Kochman K; Roth GS
    Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.
    De Montis GM; Devoto P; Gessa GL; Meloni D; Porcella A; Saba P; Serra G; Tagliamonte A
    Eur J Pharmacol; 1990 May; 180(1):31-5. PubMed ID: 2163864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.